These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Anti-HIV agents. Using only lopinavir/ritonavir (Kaletra). TreatmentUpdate; 2008 Jan; 20(1):1-2. PubMed ID: 18320690 [No Abstract] [Full Text] [Related]
3. Anti-HIV agents. A protease-only regimen--Kaletra and saquinavir. TreatmentUpdate; 2004; 16(3):8. PubMed ID: 17216837 [No Abstract] [Full Text] [Related]
4. Two studies show Kaletra and Isentress similarly suppress HIV, yet have different side effects. Proj Inf Perspect; 2009 Mar; (48):6. PubMed ID: 19492458 [No Abstract] [Full Text] [Related]
9. Prezista fares better than Kaletra in first line therapy. Proj Inf Perspect; 2009 Mar; (48):7-8. PubMed ID: 19492459 [No Abstract] [Full Text] [Related]
10. Anti-HIV agents. Lopinavir--results after one year. TreatmentUpdate; 2001; 12(8):1-2. PubMed ID: 12132436 [No Abstract] [Full Text] [Related]
11. The state of access to Kaletra. Huff B GMHC Treat Issues; 2006; 20(4-7):4-5. PubMed ID: 17228448 [No Abstract] [Full Text] [Related]
12. Kaletra single agent HAART after intolerance of NRTI- and NNRTI-containing regimens following kidney transplantation. Schürmann D; Wesselmann H; Kurowski M; Suttorp N; Reinke P Infection; 2007 Jun; 35(3):194-6. PubMed ID: 17565464 [TBL] [Abstract][Full Text] [Related]
13. ABT-378/r helpful in failing patients. AIDS Patient Care STDS; 2000 May; 14(5):281-2. PubMed ID: 10833817 [No Abstract] [Full Text] [Related]
14. FDA notifications. FDA approves half-strength Kaletra. AIDS Alert; 2008 Jan; 23(1):10. PubMed ID: 18572474 [No Abstract] [Full Text] [Related]
15. Drug interactions. Coming soon--a new formulation of Kaletra. TreatmentUpdate; 2006; 18(3):7. PubMed ID: 17209241 [No Abstract] [Full Text] [Related]
16. FDA notifications. Abbott sends out provider letter about Kaletra for kids. AIDS Alert; 2007 Oct; 22(10):118. PubMed ID: 18416010 [No Abstract] [Full Text] [Related]